Type 2 Diabetes Prevalent Among People Living With HIV
Approximately 1 in 5 people with HIV also has prevalent DM, and control of hemoglobin A1c levels in these patients may have a beneficial effect on CD4 counts.
Diabetes
Delafloxacin Effectively Treats Community-Acquired Bacterial Pneumonia in Patients With Diabetes
Researchers conducted a Phase 3 trial of patients with community acquired bacterial pneumonia and diabetes to compare delafloxacin treatment with moxiflocacin.
CD4+ T Lymphocytes May Contribute to Diabetes in Women With HIV
In women with HIV and diabetes mellitus, CD4+ lymphocytes may contribute to the development of diabetes mellitus.
SGLT-2 Inhibitor Use Not Linked to Increased Risk for UTI Events
Initiation of therapy with SGLT-2 inhibitors for T2D mellitus is not associated with an increased risk for UTI events compared with initiation of other second-line antidiabetic medications.
Pathogens, Drug Resistance in People With Diabetes, Acute Cerebral Infarction and Pulmonary Infection
Multidrug-resistant gram-negative bacilli were the pathogens commonly found in patients with acute cerebral infarction complicated by diabetes mellitus and nosocomial pulmonary infection.
Diabetes and BMI Associated With Newly Diagnosed Active Tuberculosis
An association has been identified between newly diagnosed active tuberculosis, diabetes, and body mass index.
Factors Linked to Pneumococcal Vaccination Status in Type 2 Diabetes
Patients with diabetes are at higher risk for hospitalization and mortality because of pneumococcal infection; however, uptake of vaccination remains suboptimal.
Increased Risk for Type 2 Diabetes in People With HIV and Lipodystrophy
People living with HIV, non-alcoholic fatty liver disease, and antiretroviral-associated lipodystrophy may be at an increased risk of developing type 2 diabetes.
Insulin Resistance in Adults Infected With HIV
Insulin resistance has been identified as a key driver of CVD and other complications in people living with HIV.
Direct-Acting Agents for Hepatitis C Reduce Risk for Incident Diabetes
In a large cohort of patients with HCV, the use of DAA was associated with significantly lower incidence and risk for subsequent diabetes.
- Loading...
Loading...
Next post in Hepatitis
Loading... 
Loading...